Literature DB >> 3535732

Peripheral and central primitive neuroectodermal tumors. A nosologic concept seeking a consensus.

L P Dehner.   

Abstract

The term primitive neuroectodermal tumor is widely used in the literature for a group of small, round-cell tumors in the central and sympathetic nervous systems and soft tissues as well as a specific diagnostic term for individual neoplasms; however, the contention that these various clinicopathologic entities (neuroblastoma, medulloblastoma, and peripheral neuroepithelioma) are histogenetically related is an unproved hypothesis. Morphologic, cytogenetic, immunohistochemical, biochemical, and in vitro studies have established phenotypic similarities among these putatively related neoplasms whether they originate in the brain, adrenal gland, or soft tissues. Because one tumor resembles another in terms of its phenotypic expression, that does not necessarily imply a common histogenesis. This point has been made by previous investigators. The purpose of this review is to evaluate and discuss the present status of our understanding and some of the controversial aspects of this enigmatic category of neoplasms, mainly occurring in children, known as the primitive neuroectodermal tumors.

Entities:  

Mesh:

Year:  1986        PMID: 3535732

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN: 0003-9985            Impact factor:   5.534


  41 in total

1.  Bipolar (neural and myoblastic) phenotype in cell lines derived from human germ cell tumours of testis.

Authors:  S Navarro; R Noguera; A Peydró-Olaya; A Llombart-Bosch
Journal:  Virchows Arch       Date:  1997-04       Impact factor: 4.064

2.  A paediatric supratentorial primitive neuroectodermal tumour associated with malignant astrocytic transformation and a clonal origin of both components.

Authors:  Susanne A Kuhn; Uwe-Karsten Hanisch; Kristian Ebmeier; Christian Beetz; Michael Brodhun; Rupert Reichart; Christian Ewald; Thomas Deufel; Rolf Kalff
Journal:  Neurosurg Rev       Date:  2007-02-27       Impact factor: 3.042

3.  Nerve growth factor receptor expression in peripheral and central neuroectodermal tumors, other pediatric brain tumors, and during development of the adrenal gland.

Authors:  D L Baker; W M Molenaar; J Q Trojanowski; A E Evans; A H Ross; L B Rorke; R J Packer; V M Lee; D Pleasure
Journal:  Am J Pathol       Date:  1991-07       Impact factor: 4.307

4.  Cerebral primitive neuroectodermal tumor in an adult, with spinal cord metastasis after 18-year dormancy.

Authors:  D N Louis; F H Hochberg
Journal:  J Neurooncol       Date:  1990-08       Impact factor: 4.130

5.  The imaging features of meningeal Ewing sarcoma/peripheral primitive neuroectodermal tumours (pPNETs).

Authors:  Z Jing; L Wen-Yi; L Jian-Li; Z Jun-Lin; D Chi
Journal:  Br J Radiol       Date:  2014-07-02       Impact factor: 3.039

Review 6.  Ewing sarcoma/peripheral primitive neuroectodermal tumor and related tumors.

Authors:  Maria Tsokos; Rita D Alaggio; Louis P Dehner; Paul S Dickman
Journal:  Pediatr Dev Pathol       Date:  2012

7.  Neuroectodermal tumors of the peripheral and the central nervous system share neuroendocrine N-CAM-related antigens with small cell lung carcinomas.

Authors:  W M Molenaar; L de Leij; J Q Trojanowski
Journal:  Acta Neuropathol       Date:  1991       Impact factor: 17.088

8.  Immunohistochemical characterization of primitive neuroectodermal tumors and their possible relationship to the stepwise ontogenetic development of the central nervous system. 2. Tumor studies.

Authors:  R Kleinert
Journal:  Acta Neuropathol       Date:  1991       Impact factor: 17.088

9.  Peripheral neuroectodermal tumor of the chest (Askin tumor) as secondary neoplasm after Hodgkin's disease: a case report.

Authors:  A P Anselmo; C Cartoni; A Pacchiarotti; E Pescarmona; A Cafolla; E Rendina; F Mandelli
Journal:  Ann Hematol       Date:  1994-06       Impact factor: 3.673

10.  Human melanoma-associated antigen expression on human neuroblastoma cells: effects of differentiation inducers.

Authors:  V Feyles; W T Dixon; L K Sikora; R C McGarry; L M Jerry
Journal:  Cancer Immunol Immunother       Date:  1991       Impact factor: 6.968

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.